Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRB | P24530 | 16/20 | 0.59 |
| ▸ | EDNRA | P25101 | 13/20 | 0.57 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.36 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.36 |
| ▸ | SERPINE1 | P05121 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8547308 | 0.94 | EDNRB (0.59) | EDNRBEDNRAAGTR1AGTR2SERPINE1 | |
| SCHEMBL8551305 | 0.90 | EDNRB (0.47) | EDNRBEDNRAAGTR1AGTR2 | |
| SCHEMBL8550814 | 0.90 | EDNRB (0.53) | EDNRBEDNRAAGTR1AGTR2 | |
| SCHEMBL8552257 | 0.89 | EDNRB (0.58) | EDNRBEDNRAAGTR1AGTR2SERPINE1 | |
| SCHEMBL8549513 | 0.88 | EDNRB (0.57) | EDNRBEDNRAAGTR1AGTR2 | |
| SCHEMBL8655564 | 0.87 | EDNRB (0.56) | EDNRBEDNRAAGTR2SERPINE1 | |
| SCHEMBL8548124 | 0.87 | EDNRB (0.56) | EDNRBEDNRASERPINE1 | |
| SCHEMBL8551966 | 0.87 | EDNRB (0.69) | EDNRBEDNRASERPINE1 | |
| SCHEMBL8552691 | 0.87 | EDNRB (0.43) | EDNRBEDNRAAGTR1AGTR2 | |
| SCHEMBL8624241 | 0.85 | EDNRB (0.52) | EDNRBEDNRAAGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0863898-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | MERCK PATENT GmbH (DE) | 1998-09-16 | — | — | EP | disclosed |
| WO-1997019077-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1997-05-29 | — | — | WO | disclosed |